Information Transfer Sample Clauses

Information Transfer. The Parties agree and acknowledge that Infinity has delivered to Novartis the information pursuant to Sections 2.2.4 and 3.3.3 of the Collaboration Agreement. From time to time during the term of this License Agreement, the Parties shall discuss any other information Controlled by Infinity that is necessary or useful for further development, manufacture and commercial exploitation and distribution of an Optioned Lead Program, Optioned Lead Program Compounds or Licensed Drug Product and Infinity shall promptly thereafter deliver such information to Novartis. This information shall also include copies of all Patents filed by Infinity pursuant to Section 2.3.2(h) of the Collaboration Agreement.

Information Transfer. During the performance period of this Agreement, either party shall treat the confidential information obtained by the other party related to the Project with caution and shall not disclose to any third party and keep the relevant customer information strictly confidential; Neither party shall collect and use the customer information in violation of the provisions of laws and administrative regulations and the customer information in accordance with the provisions of laws and administrative regulations and the agreement with users. Party B undertakes to take appropriate technical and organizational measures to ensure the safety of the personal information that it handles during the performance of its contractual obligations. In the case of contract termination or no longer need for the processing of personal information, Party B shall delete the personal information in time. Party B shall only process personal information within the scope necessary for the performance of this Contract and shall not process personal information for other purposes.

Information Transfer. There are policies, procedures and agreements concerning information transfer to/from third parties.

Information Transfer i) With respect to Jamf’s Hosted Services, Customer Content is encrypted in-transit to the Hosted Services and maintained in encrypted storage. Jamf will use industry standard encryption to encrypt Customer Content. ii) Jamf will restrict access through encryption to Customer Content stored on media that is physically transported from Jamf facilities. iii) Jamf will ensure that it is possible to verify and establish the extent to which Customer Content has been or may be transmitted or made available using data communication equipment.

Information Transfer. As referenced in OSHA l9l0.269(a)(3) and (a)(4), before any electric power generation, transmission, or distribution work begins, the appropriate Avangrid Representative shall provide the Contractor access to the following information:

Information Transfer. As referenced in OSHA 1910.269(a)(3) and (a)(4), before work begins, the appropriate Company User’s Representative shall provide the Contractor access to the follow information: • The existing characteristics and conditions of the Company installations that are related to the safety of the work to be performed; • Information about the design and operation of the Company installations that the Contractor needs; • Arc flash studies; • Ground fault studies; • Voltage levels for tree trimming operations; and • Danger poles tagging. As referenced in OSHA 1910.269(a)(3), the Contractor shall ensure that each of its employees is instructed in hazardous conditions relevant to the work, and the Contractor shall advise the Company of any hazardous conditions found before and during the work.

Information Transfer. TMRC shall, within [**] days after the Effective Date, provide Syros with all information that was made available to Syros in the Data Room and any other Licensed Know-how Rights possessed by TMRC or its Affiliates or in respect of which TMRC or its Affiliates otherwise have the right to grant licenses as of the Effective Date. Thereafter, on at least a [**] basis or more frequently as may be requested by Syros, TMRC shall provide Syros with updates to any chemistry, manufacturing and controls information relating to the Technology possessed by or otherwise available to TMRC or its Affiliates, if any, and with copies of or access to any other information within the Licensed Know-how Rights that Syros may request to satisfy requirements for Registrations or other required submissions to Competent Authorities, including source data and documents underlying any Registration and/or other regulatory documents to which Syros’s Right of Reference under Section 3.3 applies.

Information Transfer. Myogen shall deliver (to the extent not previously delivered to NIBRI pursuant to the Collaboration Agreement) as promptly as practicable to NIBRI all information in Myogen’s possession or under its control (including summaries of raw data from clinical studies conducted by Myogen of each Active Compound and related Myogen Target comprising the Development Candidate), all scientific reports, and all processes and procedures that are necessary or useful for further development, manufacture and commercial exploitation and distribution of the Development Candidate in the Territory. Such information shall include a summary of all material written communications (copies of which Myogen will provide to NIBRI at NIBRI’s request) between Myogen or (to the extent available to Myogen) its other licensees and the Food and Drug Administration (or any other similar regulatory authority) concerning the Development Candidate. This information shall also include copies of all Patents, copyrights, copyright registrations and applications therefor and all other manifestations of the intellectual property embodied in the Development Candidate, whether in human or machine readable form. Information provided by Myogen will be subject to the provisions of Article VI hereof.

Information Transfer. In addition to the information required to be provided to the other Party in other provisions of this Agreement, each Party shall timely provide the other Party with (i) copies of all written correspondence with the Regulatory Authorities in the Territory regarding the Initial Product for use in the Territory, and (ii) a written summary of all oral communications with the Regulatory Authorities in the Territory regarding the Initial Product.